EMA Authorised: Miglustat Dipharma (miglustat) — Dipharma Arzneimittel GmbH

View source ↗

Summary

The EMA authorised Miglustat Dipharma (miglustat) by Dipharma Arzneimittel GmbH for Gaucher disease, granting a European marketing authorization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease

Drugs mentioned

• Miglustat Dipharma (miglustat)

Snippet

Status: Authorised. Therapeutic area: Gaucher Disease. MAH: Dipharma Arzneimittel GmbH. Decision date: 16/06/2025